This prospective validation study aims to investigate the incidence of PPAP after pancreaticoduodenectomy (PD) by applying the ISGPS definition and grading system, to demonstrate its clinical impact by examining associated postoperative outcomes, and to validate its applicability through an economic assessment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The incidence of PPAP
Timeframe: 30 postoperative days
The incidence of unplanned ICU admissions and hospital readmission in the PPAP group compared to the non-PPAP one.
Timeframe: 30 postoperative days
The difference in length of hospital stay between the PPAP and the non-PPAP group
Timeframe: up to hospital discharge, an average of 30 postoperative days
The difference in hospital costs among the different grades of severity according to the ISGPS grading system22: no PPAP or POH, POH, PPAP grade B, and PPAP grade C groups.
Timeframe: 30 postoperative days